Posted from: Thursday, September 18, 2014 - 02:12 PM - Present

Cephalexin Recalled

August 25, 2014 – Caraco Pharmaceuticals, a subsidiary of Sun Pharmaceuticals recalled more the 450,000 units of antibiotic with the active ingredient cephalexin.  Cephalexin was not produced according to the US Food and Drug Administration (FDA) standards for good manufacturing practices.


Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.

Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval.  Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval.  Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.

*This is provided for information only.  The reference to any medication above does not mean the medication is covered by your plan.


Last Updated Sunday, October 20, 2019 - 10:00 PM.